CompletedNot Applicable

Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)

Sweden187 participantsStarted 2006-11

Plain-language summary

The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma

Who can participate

Age range18 Years – 64 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18-64 * Clinical diagnosis of Asthma * Glucocorticoid treatment \> 6 months. * Verified Allergy * Read and speak Swedish Exclusion Criteria: * Smoking * Current regular treatment with long-acting beta2-agonist * Treatment with Singulair only or in combination with glucocorticoids * Taking part in other research study * Pregnancy or breast-feeding * Unstable Asthma

What they're measuring

Mini-AQLQ (Asthma-Related Quality of Life)

Timeframe: 1 year

Trial details

NCT IDNCT00421018

SponsorKarolinska Institutet

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2010-04

View on ClinicalTrials.gov More Allergic Asthma trials